Skip to main content
. 2019 Aug 8;42(4):1329–1342. doi: 10.3892/or.2019.7273

Figure 6.

Figure 6.

Association between SMC1 expression and clinicopathologic parameters in patients with CRC. (A) Transcriptional expression of SMC1 in CRC tissues compared with matched adjacent normal tissues as determined by reverse transcription-quantitative PCR analysis (Wilcoxon signed-rank test). Relative expression is shown as a log2 value of the adjacent value. (B) SMC1 expression in early-stage and advanced-stage CRC tissues. (C and D) Protein expression of SMC1 in CRC tissues as determined via immunohistochemistry. (E) Kaplan-Meier analysis of overall survival of patients with CRC based on SMC1 expression. *P<0.05. CRC, colorectal cancer; SMC1, structural maintenance of chromosomes 1.